Morse Asset Management, Inc Moderna, Inc. Transaction History

Morse Asset Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$135.66 - $197.02 $585,644 - $850,535	4,317 New	4,317 $663,000
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $1.51 Million - $2.46 Million	-6,667 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$221.9 - $484.47 $19,305 - $42,148	87 Added 1.32%	6,667 $2.57 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $465,077 - $841,228	3,580 Added 119.33%	6,580 $1.55 Million
Q1 2021 May 13, 2021	BUY	$109.18 - $185.98 $327,540 - $557,940	3,000 New	3,000 $393,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Morse Asset Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Morse Asset Management, Inc with notifications on news.